The present disclosure relates generally to intravenous catheters, and more particularly to closed system intravenous catheter assemblies having an improved catheter design and method of production.
Intravenous (IV) therapy is a versatile technique used for the administration of medical fluids to and withdrawal of bodily fluids from patients. IV therapy has been used for various purposes, such as the maintenance of blood and electrolyte balance, the transfusion of blood, the administration of nutritional supplements, chemotherapy, and the administration of drugs and medications. These fluids, collectively referred to herein as medicaments, may be administered intravenously by injection through a hypodermic needle, or intermittently or continuously by infusion using a needle or catheter. A common intravenous access device utilized by clinicians is the Peripheral Intravenous Catheter (PIVC).
A PIVC is made of a soft, flexible plastic or silicone, generally between fourteen to twenty-four gauge in size. In the conventional venipuncture procedure, a catheter is inserted into a vein in the patient's hand, foot, or the inner aspect of the arm or any vein in the body that will accept an IV catheter. Typically PIVCs are “over the needle” catheters, where a catheter is coaxially placed over an introducer needle of an intravenous catheter insertion device. In order to properly place the catheter into the patient's vein, the introducer needle is used to puncture the skin, tissue, and vein wall to provide a path for placement of the catheter into the vein.
Placement of the catheter generally includes preparation of a biological site of the patient. Often a tourniquet is applied proximal to the biological site and a variety of techniques can be used to dilate the patient's vein. While wearing disposable gloves, the clinician cleanses the biological site and a vein is retracted or anchored by placing a thumb over the vein about fifty to seventy five mm distal to the site. The introducer needle and catheter are introduced into the vein by inserting a beveled sharpened tip of the introducer needle into the vein at about a twenty to thirty degree angle, with the bevel facing up in order to pierce one wall of the vein. The catheter thus rides with the introducer needle through the skin, tissue, and vein wall into the patient's vein. To finish placement, the introducer needle and catheter are lowered towards the skin to decrease the entry angle, and the catheter is advanced slightly into the vein. Once the catheter is satisfactorily positioned within the vein, the introducer needle is typically withdrawn from inside the catheter, and the connection between the catheter and the intravenous catheter device is loosened, so that the catheter can be advanced further into the vein as desired. The catheter can then be secured in place on the biological site by adhesive tape, while the intravenous catheter insertion device is properly disposed of in a sharps container.
In some cases, the PIVC defines a side port operably connectable to an IV fluid supply or other medical device, often via a pre-attached extension tube having a Luer lock connector positioned some distance away from the insertion site, thereby promoting ease-of-use and minimizing patient discomfort. Such catheters are often referred to as “closed system” catheters, as they typically include a septum that seals the needle path after the introducer needle has been withdrawn from the catheter, thereby inhibiting blood or bodily fluid from the patient from escaping from the catheter to the ambient environment, and reducing the risk of exposure of blood or other bodily fluids to clinicians, particularly a consideration of sensitivity were blood borne disease may be present. With such catheters, it is common that the septum is breached a single time (i.e., with the passage of the insertion needle therethrough). After withdrawal of the insertion needle, the septum closes, thereby permanently sealing a proximal end of the catheter hub such that the flow of fluid through the catheter is directed through the side port. Over the years, various efforts have been made to simplify the construction of closed system catheters, with the goal of reducing overall production costs. For example, U.S. Pat. Publ. Nos. 2016/0220805 and 2017/0239443, the disclosures of which are hereby incorporated herein by reference in their entirety, disclose a number of catheter hub designs configured to improve functionality, while reducing production costs. Nevertheless, there is an ever present need to further streamline manufacturing and reduce production costs. The present disclosure addresses these concerns.
Embodiments of the present disclosure provide an improved design and method of production configured to reduce cost and assembly time of a closed system catheter. In particular, embodiments of the present disclosure eliminate the adding of a septum to catheter assembly as a separate, stand-alone component; rather, the catheter hub is specifically adapted to enable the septum to be injection molded directly into a partially assembled catheter assembly. Molding a septum into the catheter hub alleviates a manufacturer of the burden of intricately positioning a separate, stand-alone within the catheter hub during construction, as molding a septum into the catheter hub ensures that the septum is properly positioned. Molding a septum into the catheter hub also enables the septum to be shaped and sized to reduce voids or pockets within an internal fluid passageway of the catheter hub where slower moving fluid flowing therethrough may tend to stagnate.
One embodiment of the present disclosure provides a method of constructing a catheter assembly having an integrated septum, including: holding a catheter hub having a distal end, a proximal end, and an internal wall defining an internal fluid passageway therebetween, the internal wall defining an injection mold window located between the distal end in the proximal end; seating a catheter tube within the internal fluid passageway of the catheter hub, such that a proximal end of the catheter tube resides within the internal fluid passageway of the catheter hub, and a distal end of the catheter tube extends distally from the distal end of the catheter hub; plugging at least the proximal end of the catheter hub with the mold core shutoff pin; and injection molding a septum in at least a portion of the internal fluid passageway between the mold core shutoff pin and the proximal end of the catheter tube through the injection mold window.
In one embodiment, the method further comprises defining a slit and/or pierce in the septum. In one embodiment, the method further comprises adding a proximal hub component to the proximal end of the catheter hub to actually compress the septum. In one embodiment, the method further comprises overmolding wings around at least a portion of the catheter hub concurrently with the molding of the septum. In one embodiment, the internal wall of the catheter hub further defines a side port in communication with the internal fluid passageway. In one embodiment, the method further comprises operably coupling a length of tubing to the side port. In one embodiment, the septum extends at least partially through the injection mold window, thereby eating in the retention of the septum within the internal fluid passageway.
Another embodiment of the present disclosure provides a method of constructing a catheter assembly having an integrated septum, including loading a catheter tube having a proximal end and a distal end into a catheter assembly mold; overmolding a catheter hub around at least the proximal end of the catheter tube, the catheter hub having a distal end, a proximal end, and an internal wall defining an internal fluid passageway therebetween, the internal wall defining an injection mold window located between the distal end in the proximal end; plugging at least the proximal end of the catheter hub with the mold core shutoff pin; and injection molding a septum in at least a portion of the internal fluid passageway between the mold core shutoff pin and the proximal end of the catheter tube through the injection mold window.
Another embodiment of the present disclosure provides a catheter assembly having an integrated septum. The catheter assembly can include a catheter hub, a catheter tube, and a septum. The catheter hub can have a distal end, a proximal end, and an internal wall defining an internal fluid passageway therebetween. The internal wall can further define an injection mold window located between the distal end in the proximal end. The catheter tube can be positioned within the catheter hub, such that a proximal end of the catheter hub resides within the internal fluid passageway of the catheter hub, and a distal end of the catheter tube extends distally from the distal end of the catheter hub. The septum can fill at least a portion of the internal fluid passageway between the proximal end of the catheter hub and a proximal end of the catheter tube, the septum can extend at least partially through the injection mold window.
The summary above is not intended to describe each illustrated embodiment or every implementation of the present disclosure. The figures and the detailed description that follow more particularly exemplify these embodiments.
The disclosure can be more completely understood in consideration of the following detailed description of various embodiments of the disclosure, in connection with the accompanying drawings, in which:
While embodiments of the disclosure are amenable to various modifications and alternative forms, specifics thereof shown by way of example in the drawings will be described in detail. It should be understood, however, that the intention is not to limit the disclosure to the particular embodiments described. On the contrary, the intention is to cover all modifications, equivalents, and alternatives falling within the spirit and scope of the subject matter as defined by the claims.
Referring to
In one embodiment, the internal fluid passageway 208 can define a side port 210 in communication with the internal fluid passageway 208. In some embodiments, a length of hollow tubing 212 (depicted in
In one embodiment, the internal fluid passageway 208 can define an injection mold window 218 located between the distal end 202 and the proximal end 204. The injection mold window 218 can be appropriately sized and shaped to enable the flow of injection molded material under pressure into the internal fluid passageway 208 of the mold catheter hub 200. For example, in one embodiment, the injection mold window 218 can be rectangular in shape, and can be positioned between the proximal end 204 of the catheter hub and the side port 218 defined by the internal wall 206.
In one embodiment, the catheter hub 200 can further include one or more ledges 220 configured to provide structural reinforcement as support for a wing assembly. In one embodiment, the ledges 220 can define one or more holes 222. The holes 222 can provide improved contact with the wing assembly, when the wing assembly is integrally molded onto a portion of the catheter hub 200. Accordingly, the ledges 220 can serve to both increase the bonding surface between the catheter hub 200 and the wing assembly, as well as to serve as a partial structural reinforcement for the wing assembly, while at the same time enabling the assembly to maintain its flexibility.
With continued reference to
With continued reference to
With continued reference to
In one embodiment, catheter hub wings 502 can be overmolded onto at least a portion of the catheter hub 200 concurrently with the molding of the septum 500. In particular, the catheter hub wings 502 can be overmolded over the one or more ledges 220 of the catheter hub, such that the overmolded catheter hub wing material flows into the one or more holes 222 defined within the one or more ledges 220.
Referring to
Moreover, as the septum 500 is injection molded into the catheter hub 200 and the disclosed process 100, the assembly step of inserting a separate, stand-alone septum into a catheter hub common to conventional assembly processes can be eliminated. Accordingly, embodiments of the present disclosure result in a faster and more streamlined assembly process, as well as a more robust catheter assembly 600.
With continued reference to
At 112, a proximal hub component 224 can be optionally added to the proximal end 204 of the catheter hub 200, thereby axially compressing the molded septum 500. Axial compression of the molded septum 500 can aid in inhibiting bodily fluid from flowing through the slit 504 or pierce defined within the septum 500. In some embodiments, the proximal hub component 224 can further be configured to mate with a needle insertion device (such as that depicted in
Referring to
At 706, portions of the internal fluid passageway 208 extending to the exterior of the catheter hub 200 can be plugged in anticipation of molding the septum. Like process 100, this can optionally include a proximal end catheter hub molding core shut off pin 400A, a side port molding core shut off pin 400B, and a bushing 402 positioned over at least a portion of the catheter hub 200 to inhibit injection molded material from entering those portions of the assembly. At 708, a quantity of injection molded material can be injected through the injection mold window 218 of the catheter hub 202, thereby filling a portion of the internal fluid passageway 208 to form the septum 500. In one embodiment, catheter hub wings 502 can be overmolded onto at least a portion of the catheter hub 200 concurrently with the molding of the septum 500.
At 710, a slit 504 or pierce can optionally be defined in the septum 500. At 712, a proximal hub component 224 can be optionally added to the proximal end 204 of the catheter hub 200, thereby axially compressing the molded septum 500.
It should be understood that the individual steps used in the methods of the present teachings may be performed in any order and/or simultaneously, as long as the teaching remains operable. Furthermore, it should be understood that the apparatus and methods of the present teachings can include any number, or all, of the described embodiments, as long as the teaching remains operable.
It is also to be appreciated that the term “distal,” as used herein, refers to the direction along an axis that lies parallel to a needle cannula of a safety catheter assembly that is closest to the subject during catheter insertion. Conversely, the term “proximal,” as used herein, refers to the direction lying along the axis parallel to the needle cannula that is further away from the subject when the catheter is inserted into the vein of the subject, opposite to the distal direction.
Various embodiments of systems, devices, and methods have been described herein. These embodiments are given only by way of example and are not intended to limit the scope of the claimed inventions. It should be appreciated, moreover, that the various features of the embodiments that have been described may be combined in various ways to produce numerous additional embodiments. Moreover, while various materials, dimensions, shapes, configurations and locations, etc. have been described for use with disclosed embodiments, others besides those disclosed may be utilized without exceeding the scope of the claimed inventions.
Persons of ordinary skill in the relevant arts will recognize that the subject matter hereof may comprise fewer features than illustrated in any individual embodiment described above. The embodiments described herein are not meant to be an exhaustive presentation of the ways in which the various features of the subject matter hereof may be combined. Accordingly, the embodiments are not mutually exclusive combinations of features; rather, the various embodiments can comprise a combination of different individual features selected from different individual embodiments, as understood by persons of ordinary skill in the art. Moreover, elements described with respect to one embodiment can be implemented in other embodiments even when not described in such embodiments unless otherwise noted.
Although a dependent claim may refer in the claims to a specific combination with one or more other claims, other embodiments can also include a combination of the dependent claim with the subject matter of each other dependent claim or a combination of one or more features with other dependent or independent claims. Such combinations are proposed herein unless it is stated that a specific combination is not intended.
Any incorporation by reference of documents above is limited such that no subject matter is incorporated that is contrary to the explicit disclosure herein. Any incorporation by reference of documents above is further limited such that no claims included in the documents are incorporated by reference herein. Any incorporation by reference of documents above is yet further limited such that any definitions provided in the documents are not incorporated by reference herein unless expressly included herein.
For purposes of interpreting the claims, it is expressly intended that the provisions of 35 U.S.C. § 112(f) are not to be invoked unless the specific terms “means for” or “step for” are recited in a claim.
The present application claims the benefit of U.S. Provisional Application No. 62/736,266 filed Sep. 25, 2018, which is hereby incorporated herein in its entirety by reference.
Number | Name | Date | Kind |
---|---|---|---|
3470604 | Zenick | Oct 1969 | A |
3720210 | Diettrich | Mar 1973 | A |
4523968 | McCool | Jun 1985 | A |
4755649 | Barker | Jul 1988 | A |
4802947 | Bartholomew | Feb 1989 | A |
4846809 | Sims | Jul 1989 | A |
4964854 | Luther | Oct 1990 | A |
5322518 | Schneider | Jun 1994 | A |
5403291 | Abrahamson | Apr 1995 | A |
5480380 | Martin | Jan 1996 | A |
5510065 | McFarlane | Apr 1996 | A |
5713849 | Bosma | Feb 1998 | A |
5749857 | Cuppy | May 1998 | A |
5800399 | Bogert | Sep 1998 | A |
5800410 | Gawreluk | Sep 1998 | A |
5810869 | Kaplan | Sep 1998 | A |
6192568 | Kafrawy | Feb 2001 | B1 |
6616630 | Woehr | Sep 2003 | B1 |
6837873 | Polley | Jan 2005 | B1 |
7670317 | Cindrich | Mar 2010 | B2 |
7799400 | Zihlmann | Sep 2010 | B2 |
RE45896 | Stout | Feb 2016 | E |
11071849 | Ng | Jul 2021 | B2 |
20020120231 | Douglas | Aug 2002 | A1 |
20030088213 | Schweikert | May 2003 | A1 |
20040034333 | Seese | Feb 2004 | A1 |
20040097903 | Raulerson | May 2004 | A1 |
20040167478 | Mooney | Aug 2004 | A1 |
20040243103 | King | Dec 2004 | A1 |
20050033237 | Fentress | Feb 2005 | A1 |
20050040557 | Flynn | Feb 2005 | A1 |
20050059958 | Lessard | Mar 2005 | A1 |
20050070878 | Triplett | Mar 2005 | A1 |
20050080398 | Markel | Apr 2005 | A1 |
20050234499 | Olson | Oct 2005 | A1 |
20060264821 | Vo | Nov 2006 | A1 |
20070196414 | Hammarsten | Aug 2007 | A1 |
20070260221 | Chesnin | Nov 2007 | A1 |
20080009832 | Barron | Jan 2008 | A1 |
20080097344 | McKinnon | Apr 2008 | A1 |
20080214991 | Haarala | Sep 2008 | A1 |
20080294145 | Eddings | Nov 2008 | A1 |
20090005741 | Martin | Jan 2009 | A1 |
20090069792 | Frey | Mar 2009 | A1 |
20090093794 | Holtz | Apr 2009 | A1 |
20090157052 | Verbitsky | Jun 2009 | A1 |
20100102490 | Smith | Apr 2010 | A1 |
20100130939 | Voss | May 2010 | A1 |
20100204648 | Stout | Aug 2010 | A1 |
20120004622 | Leeflang | Jan 2012 | A1 |
20120150130 | Triel | Jun 2012 | A1 |
20120296290 | Argauer | Nov 2012 | A1 |
20130053826 | Shevgoor | Feb 2013 | A1 |
20130090608 | Stout | Apr 2013 | A1 |
20130218082 | Hyer | Aug 2013 | A1 |
20140074028 | Sonderegger | Mar 2014 | A1 |
20140128820 | Braga | May 2014 | A1 |
20140180261 | Nyman | Jun 2014 | A1 |
20140249487 | Lynn | Sep 2014 | A1 |
20140306383 | Harding | Oct 2014 | A1 |
20150051583 | Horvath | Feb 2015 | A1 |
20150157827 | Glasel | Jun 2015 | A1 |
20150190612 | Schaffner | Jul 2015 | A1 |
20150219255 | Reuter | Aug 2015 | A1 |
20150306368 | Lin | Oct 2015 | A1 |
20160008569 | Harding | Jan 2016 | A1 |
20160008570 | Glozman | Jan 2016 | A1 |
20160220791 | Akcay | Aug 2016 | A1 |
20160220805 | Goral | Aug 2016 | A1 |
20170119997 | Burkholz | May 2017 | A1 |
20170151417 | Takemura | Jun 2017 | A1 |
20170239443 | Abitabilo | Aug 2017 | A1 |
20180093085 | Burkholz | Apr 2018 | A1 |
20180161540 | Fantuzzi | Jun 2018 | A1 |
20190022367 | Burkholz | Jan 2019 | A1 |
20190321616 | Akahori | Oct 2019 | A1 |
20200009366 | Abitabilo et al. | Jan 2020 | A1 |
Number | Date | Country |
---|---|---|
2008-532663 | Aug 2008 | JP |
10-2003-0065561 | Aug 2003 | KR |
WO 02051494 | Jul 2002 | WO |
WO 2019152630 | Aug 2019 | WO |
Entry |
---|
Search Report dated Jan. 23, 2020 for Application No. PCT/US2019/052613, 11 pages. |
Number | Date | Country | |
---|---|---|---|
20200094016 A1 | Mar 2020 | US |
Number | Date | Country | |
---|---|---|---|
62736266 | Sep 2018 | US |